Print

Medivation, Inc. (MDVN) Announces Participation at Upcoming Investor Conferences  
9/5/2012 9:12:44 AM

SAN FRANCISCO, CA--(Marketwire - September 04, 2012) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • Patrick Machado, chief business and financial officer, will present at the BioCentury NewsMakers in the Biotech Industry conference on September 7 at 10:00a.m. Eastern Time in New York, NY.
  • David Hung, M.D., president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on September 11 at 2:30p.m. Eastern Time in New York, NY.
  • David Hung, M.D., president and chief executive officer, will present at the UBS Global Life Sciences Conference on September 19 at 11:30a.m. Eastern Time in New York, NY.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900


//-->